Browse the corpus

Walk the evidence base by book and chapter — the raw source passages that ground Ask, Differential, and the rest.

• "Current state and prospects in managing liver transplanted children".1 passage
• "De novo" cholangiocarcinoma 20 years after liver transplantation for primary sclerosing cholangitis: Lifelong screening needed!1 passage
• "Porto-pulmonary hypertension: a comprehensive review".1 passage
• "Vascular liver diseases: Position paper(s) from the francophone network for vascular liver diseases, the French Association for the Study of the Liver (AFEF), and the European Reference Network on Hepatological Diseases (ERN RARE-LIVER)".1 passage
• (untitled)1 passage
• 5-FU or mitomycin C hepatic arterial infusion after failure of arterial oxaliplatin in patients with colorectal cancer unresectable liver metastases.1 passage
• A case of COVID-19 patient with the diarrhea as initial symptom and literature review.1 passage
• A case of esophageal tuberculosis with unusual endoscopic feature.1 passage
• A case series of eosinophilic esophagitis and primary adrenal insufficiency.1 passage
• A changing etiologic scenario in liver transplantation for hepatocellular carcinoma in a multicenter cohort study from Latin America.1 passage
• A genetic variant in the promoter region of miR-877 is associated with an increased risk of hepatocellular carcinoma.1 passage
• A letter on ABCB4 from Iceland: On the highway to liver disease.1 passage
• A long-term multicenter study: Entecavir versus Tenofovir in treatment of nucleos(t)ide analogue-naive chronic hepatitis B patients.1 passage
• A meta-analysis of single-stage versus two-stage management for concomitant gallstones and common bile duct stones.1 passage
• A meta-analysis of the efficacy and safety of iodine [1 passage
• A microbial peptide to rescue severe and fulminant Wilson disease?1 passage
• A new model based on gamma-glutamyl transpeptidase to platelet ratio (GPR) predicts prognostic outcome after curative resection of solitary hepatocellular carcinoma.1 passage
• A new pathway to eSCAPe lipotoxicity.1 passage
• A novel mutation of PCSK1 responsible for PC1/3 deficiency in two siblings.1 passage
• A novel online calculator based on noninvasive markers (ALBI and APRI) for predicting post-hepatectomy liver failure in patients with hepatocellular carcinoma.1 passage
• A pragmatic non-invasive assessment of liver fibrosis in patients with psoriasis, rheumatoid arthritis or Crohn's disease receiving methotrexate therapy.1 passage
• A predictive score of inadequate bowel preparation based on a self-administered questionnaire: PREPA-CO.1 passage
• A preliminary study of plasma cyclase-associated protein 2 as a novel biomarker for early stage and alpha-fetoprotein negative hepatocellular carcinoma patients.1 passage
• A survey of lifestyle habits, physician counseling, and direct-to consumer genetic testing in patients with hereditary hemochromatosis.1 passage
• A systematic review of NSAIDs treatment for acute pancreatitis in animal studies and clinical trials.1 passage
• A systemic mechanism of increased transendothelial migration of leukocytes through the blood-brain barrier in hepatic encephalopathy.1 passage
• A twelve-year study of the prevalence, risk factors and characteristics of interval colorectal cancers after negative colonoscopy.1 passage
• A woman presenting with an unusual cause of fulminant liver failure and sepsis.1 passage
• ART score and hepatocellular carcinoma: An appraisal of its applicability.1 passage
• ATP-binding cassette transporters expression in rats with cirrhosis and hepatic encephalopathy.1 passage
• Abdominal ascites in children as the presentation of eosinophilic gastroenteritis: A surgeon's perspective.1 passage
• Aberrant expression of deubiquitylating enzyme USP9X predicts poor prognosis in gastric cancer.1 passage
• Abnormal post-prandial glucagon-like peptide release in patients with Crohn's disease.1 passage
• Absence of impact of direct acting antivirals for hepatitis C virus on recurrent hepatocellular carcinoma tumor growth in the AFEF/ANRS CO22 Hepather cohort.1 passage
• Accuracy of microRNAs for the diagnosis of hepatocellular carcinoma: A systematic review and meta-analysis.1 passage
• Active HCV infection is associated with increased circulating levels of interferon-gamma (IFN-γ)-inducible protein-10 (IP-10), soluble CD163 and inflammatory monocytes regardless of liver fibrosis and HIV coinfection.1 passage
• Acute kidney injury in patients with cirrhosis: Prospective longitudinal study in 405 patients.1 passage
• Acute liver failure and HELLP syndrome: A clinical case and literature review.1 passage
• Acute liver failure due to DGUOK deficiency-is liver transplantation justified?1 passage
• Acute liver failure requiring transplantation caused by ulipristal acetate.1 passage
• Acute pericarditis: A rare complication of gastric variceal obturation with cyanoacrylate glue.1 passage
• Adherence to quality indicators in endoscopic surveillance of Barrett's esophagus and correlation to dysplasia detection rates.1 passage
• Adherence to ribavirin in chronic hepatitis C patients on antiviral treatment: Results from a randomized controlled trial using real-time medication monitoring.1 passage
• Adherence to ursodeoxycholic acid therapy in patients with cholestatic and autoimmune liver disease.1 passage
• Adipose tissue dysfunction and MAFLD in obesity on the scene of COVID-19.1 passage
• Adjuvant chemotherapy indications for stage I gastric cancer patients with negative lymph node.1 passage
• Adjuvant transarterial chemoembolization after curative hepatectomy for hepatocellular carcinoma with microvascular invasion: A systematic review and meta-analysis.1 passage
• Adjuvanted recombinant HBV vaccine (HBV-AS04) is effective over extended follow-up in dialysis population. An open-label non randomized trial.1 passage
• Adult autoimmune enteropathy in autoimmune hepatitis patient. Case report and literature review.1 passage
• Adult diffuse hepatic hemangiomatosis: A case report and review of the literature.1 passage
• Advanced small bowel adenocarcinoma: Molecular characteristics and therapeutic perspectives.1 passage
• Advances in cell death - related signaling pathways in acute-on-chronic liver failure.1 passage
• Advances in management of adjuvant chemotherapy in rectal cancer: Consequences for clinical practice.1 passage
• Adverse events after biliary sphincterotomy: Does the electric current mode make a difference? A systematic review and meta-analysis of randomized controlled trials.1 passage
• Aloe vera-induced acute liver injury: A case report and literature review.1 passage
• Alteration of methyl-CpG binding domain family in patients with chronic hepatitis B.1 passage
• Alterations in serum levels of fetuin A and selenoprotein P in chronic hepatitis C patients with concomitant type 2 diabetes: A case-control study.1 passage
• Aminopeptidase N (APN/CD13) as a target molecule for scirrhous gastric cancer.1 passage
• An important intestinal transporter that regulates the enterohepatic circulation of bile acids and cholesterol homeostasis: The apical sodium-dependent bile acid transporter (SLC10A2/ASBT).1 passage
• An increase in prostate cancer diagnosis during inflammatory bowel disease: A systematic review and meta-analysis.1 passage
• An observational and comparative study on intraductal papillary mucinous neoplasm of the biliary tract and the pancreas from a Chinese cohort.1 passage
• An update on the physiopathology and therapeutic management of cholestatic pruritus in children.1 passage
• Anal sphincter function as assessed by 3D high definition anorectal manometry.1 passage
• Analysis of clinical characteristics and S gene sequences in chronic asymptomatic HBV carriers with low-level HBsAg.1 passage
• Analysis of intrahepatic total HBV DNA, cccDNA and serum HBsAg level in Chronic Hepatitis B patients with undetectable serum HBV DNA during oral antiviral therapy.1 passage
• Anastomotic bilio-biliary stricture after adult liver transplantation: A retrospective study over 20 years in a single center.1 passage
• Angioedema with severe acute abdominal pain: Think of hereditary angioedema.1 passage
• Angiotensin-converting enzyme insertion/deletion polymorphism and gastric cancer: a systematic review and meta-analysis.1 passage
• Animal models of cholangiocarcinoma: What they teach us about the human disease.1 passage
• Animal naming test for the assessment of minimal hepatic encephalopathy in Asian cirrhotic populations.1 passage
• Annular pancreas: Culprit or innocent bystander?1 passage
• Antegrade papillotome navigation as a novel next-line approach for internalization of percutaneous transhepatic biliary drainage.1 passage
• Anti-E1E2 antibodies do predict response to triple therapy in treatment-experienced Hepatitis C Virus-cirrhosis cases.1 passage
• Anti-E1E2 antibodies status prior therapy favors direct-acting antiviral treatment efficacy.1 passage
• Are there variations in adherence to colorectal cancer clinical guidelines depending on treatment place and recommendation novelty? The French EvaCCoR observational study.1 passage
• Assessment of Lactobacillus casei rhamnosus (LGG) therapy in children with biliary atresia - Randomized placebo controlled trial.1 passage
• Assessment of health related quality of life in polish patients with primary biliary cirrhosis.1 passage
• Assessment of liver fibrosis by transient elastography (Fibroscan1 passage
• Association between appendectomy and risk of primary sclerosing cholangitis: A systematic review and meta-analysis.1 passage
• Association between portal vein thrombosis and risk of bleeding in liver cirrhosis: A systematic review of the literature.1 passage
• Association between rs4938723 functional polymorphism in the promoter region of miR-34b/c gene and cancer risk.1 passage
• Association between use of proton pump inhibitors and colorectal cancer: A nationwide population-based study.1 passage
• Association of FXR gene variants with cholelithiasis.1 passage
• Association of IL-10 and TGF-beta cytokine gene polymorphisms with autoimmune hepatitis.1 passage
• Association of IL-17A and IL-17F gene polymorphisms with chronic hepatitis B and hepatitis B virus-related liver cirrhosis in a Chinese population: A case-control study.1 passage
• Association of NLRP3 single nucleotide polymorphisms with ulcerative colitis: A case-control study.1 passage
• Association of STAT4 rs7574865 polymorphism with susceptibility to inflammatory bowel disease: A systematic review and meta-analysis.1 passage
• Association of glycated hemoglobin with the risk of advanced fibrosis in non-alcoholic fatty liver disease patients without diabetes.1 passage
• Association of interleukin4 gene polymorphisms of recipients and donors with acute rejection following living donor liver transplantation.1 passage
• Association of shear-wave elastography with clinical outcomes post-liver transplantation.1 passage
• Association of the pretreatment lung immune prognostic index with survival outcomes in advanced gastric cancer patients treated with immune checkpoint inhibitors.1 passage
• Association study of PNPLA2 gene with histological parameters of NAFLD in an obese population.1 passage
• Associations between the tumor necrosis factor-α gene and interleukin-10 gene polymorphisms and risk of alcoholic liver disease: A meta-analysis.1 passage
• Attenuating PI3K isoforms in pancreatic cancer: Focus on immune PI3Kγ.1 passage
• Atypical presentations of coronavirus disease 2019 in a patient with acute obstructive suppurative cholangitis.1 passage
• Autoimmune hepatitis association with single nucleotide polymorphism of interleukin-2, but not interferon-gamma.1 passage
• Autoimmune hepatitis in patients with multiple sclerosis: The role of immunomodulatory treatment.1 passage
• Autoimmune hepatitis - update on clinical management in 2017.1 passage
• Autophagy in alcoholic liver disease, self-eating triggered by drinking.1 passage
• B-cell compartment abnormalities are associated with ACLF and mortality in patients with liver cirrhosis.1 passage
• B-cell depletion induces prolonged remission in patients with giant cell hepatitis and autoimmune hemolytic anemia.1 passage
• Baseline HBsAg levels associated with HBsAg loss in HBeAg-negative chronic hepatitis B infection with persistently normal alanine aminotransferase.1 passage
• Baseline resistance associated substitutions in HCV genotype 1 infected cohort treated with Simeprevir, Daclatasvir and Sofosbuvir in Brazil.1 passage
• Beta-thalassemia major alters sofosbuvir/ledipasvir exposure in Hepatitis C virus infected adolescent patients.1 passage
• Biallelic mutations in DCDC2 cause neonatal sclerosing cholangitis in a Chinese family.1 passage
• Bile acids in drug induced liver injury: Key players and surrogate markers.1 passage
• Biliary atresia: Clinical advances and perspectives.1 passage
• Biliary calprotectin, lactoferrin and dimeric pyruvate kinase after liver transplantation are associated with biliary damage and graft survival in a case-control study.1 passage
• Biliary epithelium: A neuroendocrine compartment in cholestatic liver disease.1 passage
• Biologics for the prevention of postoperative Crohn's disease recurrence: A systematic review and meta-analysis.1 passage
• Biomarkers of oxidation stress, inflammation, necrosis and apoptosis are associated with hepatitis B-related acute-on-chronic liver failure.1 passage
• Building and verifying a severity prediction model of acute pancreatitis (AP) based on BISAP, MEWS and routine test indexes.1 passage
• C1GALT1C1/COSMC is a novel prognostic biomarker for hepatocellular carcinoma.1 passage
• CCT6A expression in hepatocellular carcinoma and its correlation with clinical characteristics, liver function indexes, tumor markers and prognosis.1 passage
• CD40 signaling and hepatic steatosis: Unanticipated links.1 passage
• CD44v6 expression is associated with a poor prognosis in Chinese hepatocellular carcinoma patients: A meta-analysis.1 passage
• CD81 passage
• CDKN2A promoter methylation and hepatocellular carcinoma risk: A meta-analysis.1 passage
• COVID-19 and liver dysfunction: Epidemiology, association and potential mechanisms.1 passage
• Cameron lesions: A still overlooked diagnosis. Case report and systematic review of literature.1 passage
• Carrying on with liver transplantation during the COVID-19 emergency: Report from piedmont region.1 passage
• Caveolin-1 promotes tumor growth and metastasis via autophagy inhibition in hepatocellular carcinoma.1 passage
• Celiac disease in children.1 passage
• Challenging issues in the management of Wilson's disease.1 passage
• Characteristic and outcomes of patients with pathologic complete response after preoperative treatment in borderline and locally advanced pancreatic adenocarcinoma: An AGEO multicentric retrospective cohort.1 passage
• Characteristics and outcome of primary Budd-Chiari syndrome due to Behçet's syndrome.1 passage
• Characteristics and prevalence of Wilson's disease: A 2013 observational population-based study in France.1 passage
• Characteristics of amino acid substitutions within the "a" determinant region of hepatitis B virus in chronically infected patients with coexisting HBsAg and anti-HBs.1 passage
• Characteristics of patients with hepatitis B virus and hepatitis C virus dual infection in a Western European country: Comparison with monoinfected patients.1 passage
• Characterization of biopsy proven non-alcoholic fatty liver disease in healthy non-obese and lean population of living liver donors: The impact of uric acid.1 passage
• Chemotherapy use in end-of-life digestive cancer patients: a retrospective AGEO observational study.1 passage
• Cholestatic hepatitis due to Ecballium elaterium ingestion.1 passage
• Chromosome region maintenance-1 (CRM1) regulates apoptosis of intestinal epithelial cells via p27kip1 in Crohn's disease.1 passage
• Chronic alcohol drinking: Liver and pancreatic cancer?1 passage
• Chronic enteropathy associated with SLCO2A1 gene: A case report and literature review.1 passage
• Chronic hepatitis B and fatty liver: Issues in clinical management.1 passage
• Chronic hepatitis C: Burden of disease and cost associated with hospitalisations in France in 2012 (The HEPC-LONE study).1 passage
• Chylous ascites due to idiopathic chronic pancreatitis managed with endoscopic stenting.1 passage
• Circulating microRNAs panel as a diagnostic tool for discrimination of HCV-associated hepatocellular carcinoma.1 passage
• Circulating microRNAs: Possible role as non-invasive diagnostic biomarkers in liver disease.1 passage
• Clinical and psychological characteristics of patients with globus.1 passage
• Clinical characteristics and management of a liver transplanted patient admitted with SARS-CoV-2 infection.1 passage
• Clinical interpretation of PRSS1 variants in patients with pancreatitis.1 passage
• Clinical outcome and long-term survival of 150 consecutive patients with pancreatic neuroendocrine tumors: A comprehensive analysis by the World Health Organization 2010 grading classification.1 passage
• Clinical outcomes and risk factors of hepatocellular carcinoma treated by liver transplantation: A multi-centre comparison of living donor and deceased donor transplantation.1 passage
• Clinical presentations of Hepatitis E: A clinical review with representative case histories.1 passage
• Clinical significance of C/D box small nucleolar RNA U76 as an oncogene and a prognostic biomarker in hepatocellular carcinoma.1 passage
• Clinical usage of serum albumin to ascitic fluid albumin gradient and ascitic fluid total protein in pediatric ascites.1 passage
• Clinicopathological assessment of steatohepatitic hepatocellular carcinoma.1 passage
• Clinicopathological features, risk of lymph node metastasis and survival outcome of synchronous multiple early gastric cancer.1 passage
• Co-expression of PDGF-B and VEGFR-3 strongly correlates with poor prognosis in hepatocellular carcinoma patients after hepatectomy.1 passage
• Coenzyme Q10 deficiency in patients with hereditary hemochromatosis.1 passage
• Coffee consumption and risk of gastric cancer: an updated meta-analysis.1 passage
• Colon ischemia: A comprehensive review.1 passage
• Combination of quantitative hepatitis B core antibody (qHBcAb) and aspartate aminotransferase (AST) can accurately diagnose immune tolerance of chronic hepatitis B virus infection based on liver biopsy.1 passage
• Combination of serum paraoxonase/arylesterase 1 and antithrombin-III is a promising non-invasion biomarker for discrimination of AFP-negative HCC versus liver cirrhosis patients.1 passage
• Combination of temsirolimus and adriamycin exhibits an enhanced antitumor effect in hepatocellular carcinoma.1 passage
• Combination therapy: New hope for alcoholic hepatitis?1 passage
• Combined early dynamic (18)F-FDG PET/CT and conventional whole-body (18)F-FDG PET/CT provide one-stop imaging for detecting hepatocellular carcinoma.1 passage
• Combined heart and liver transplantation: State of knowledge and outlooks.1 passage
• Combining cellular immunotherapy was an optional choice for unresectable advanced HCC: A systematic review and meta-analysis.1 passage
• Commentary to the paper entitled "Increased incidence of Campylobacter enteritis and their quinolone resistance between 2010 and 2015: Results of a French national observatory conducted in 21 general hospitals (CHG)".1 passage
• Comparison of Interferon-α-based therapy and nucleos(t)ide analogs in preventing adverse outcomes in patients with chronic hepatitis B.1 passage
• Comparison of endoscopic therapies for rectal carcinoid tumors: Endoscopic mucosal resection with circumferential incision versus endoscopic submucosal dissection.1 passage
• Comparison of narrow-band imaging and confocal laser endomicroscopy for the detection of neoplasia in Barrett's esophagus: A meta-analysis.1 passage
• Complete pathological response of unresectable liver metastases from colorectal cancer after trans-arterial chemoembolization with drug-eluting beads loaded with irinotecan (DEBIRI) and concomitant systemic FOLFOX: A case report from the FFCD 1201 trial.1 passage
• Comprehensive analysis of hospital-based prospective cohort reveals the unique effectiveness and safety for nucleos(t)ide analogues in HBV patients.1 passage
• Comprehensive predictive factors for CalliSpheres® microspheres (CSM) drug-eluting bead-transarterial chemoembolization and conventional transarterial chemoembolization on treatment response and survival in hepatocellular carcinoma patients.1 passage
• Concurrence of HBV infection and non-alcoholic fatty liver disease is associated with higher prevalence of chronic kidney disease.1 passage
• Congenital portosystemic shunts: Vascular liver diseases: Position papers from the francophone network for vascular liver diseases, the French Association for the Study of the Liver (AFEF), and ERN-rare liver.1 passage
• Consumption of vegetables may reduce the risk of liver cancer: results from a meta-analysis of case-control and cohort studies.1 passage
• Continuum of care for advanced biliary tract cancers.1 passage
• Contraceptive vaginal ring-induced cholestasis in a patient with a history of intrahepatic cholestasis of pregnancy.1 passage
• Correlation between the DEPDC5 rs1012068 polymorphism and the risk of HBV-related hepatocellular carcinoma.1 passage
• Covid-19 in liver transplant recipients: the French SOT COVID registry.1 passage
• Crohn's Colitis: Development of a multiplex gene expression assay comparing mRNA levels of susceptibility genes.1 passage
• Crohn's disease treatment practices in France in1999-2013: A prospective survey in non-academic hospitals.1 passage
• Crohn's disease-specific anti-CUZD1 pancreatic antibodies are absent in ruminants with paratuberculosis.1 passage
• Cryptococcosis manifesting as isolated biliary infection: Case report and brief review of literature.1 passage
• Current imaging of rectal cancer.1 passage
• Cystic fibrosis-style changes in the early phase of pancreatitis.1 passage
• Cytochrome P450 2E1 should not be neglected for acetaminophen-induced liver injury in metabolic diseases with altered insulin levels or glucose homeostasis.1 passage
• Cytomegalovirus in pediatric inflammatory bowel disease patients with acute severe colitis.1 passage
• DNA methylation as a key epigenetic player for hepatoblastoma characterization.1 passage
• De novo hepatocellular carcinoma in cirrhotic hepatitis C virus: Are directly acting antivirals beneficial?1 passage
• Decreased glucagon-like peptide-1 correlates with abdominal pain in patients with constipation-predominant irritable bowel syndrome.1 passage
• Delisting and clinical outcomes of liver transplant candidates after hepatitis C virus eradication: A long-term single-center experience.1 passage
• Demethylation of tumor necrosis factor-α converting enzyme predicts poor prognosis in acute-on-chronic hepatitis B liver failure.1 passage
• Detection of HBV DNA and antigens in HBsAg-positive patients with primary hepatocellular carcinoma.1 passage
• Determinants of short-term outcomes after pediatric liver transplantation: a single centre experience over 20 years.1 passage
• Development and validation of a robust epithelial-mesenchymal transition (EMT)-related prognostic signature for hepatocellular carcinoma.1 passage
• Diabetes mellitus increases the risk of colorectal neoplasia: An updated meta-analysis.1 passage
• Diagnosis of local hepatic tuberculosis through next-generation sequencing: Smarter, faster and better.1 passage
• Diagnostic accuracy of osteopontin plus alpha-fetoprotein in the hepatocellular carcinoma: A meta-analysis.1 passage
• Diagnostic and prognostic value of serum L1-cell adhesion molecule in esophageal squamous cell carcinoma.1 passage
• Diagnostic imaging of hepatic lymphoma.1 passage
• Diagnostic yield of esophagogastroduodenoscopy in France.1 passage
• Diarrhea: An underestimated symptom in Coronavirus disease 2019.1 passage
• Different bismuth-based therapies for eradicating Helicobacter pylori: Randomized clinical trial of efficacy and safety.1 passage
• Different clinicopathologic features and prognostic significance of signet ring cell histology in early and locally advanced gastric cancer patients.1 passage
• Differentiation of solid-pseudopapillary tumors of the pancreas from pancreatic neuroendocrine tumors by using endoscopic ultrasound.1 passage
• Direct-acting antiviral therapy enhances total CD4+ and CD8+ T-cells responses, but does not alter T-cells activation among HCV mono-infected, and HCV/HIV-1 co-infected patients.1 passage
• Diversity of humoral responses to the centromere proteins among HCV-related chronic liver disease, PBC and AIH patients.1 passage
• Do renin-angiotensin system inhibitors reduce risk for hepatocellular carcinoma?: A nationwide nested case-control study.1 passage
• Do we need endoscopic ultrasonography for the workup of patients with esophageal motility disorder?1 passage
• Does adipose tissue inflammation drive the development of non-alcoholic fatty liver disease in obesity?1 passage
• Down-regulation of C/EBP homologous protein (CHOP) expression in gastric cardia adenocarcinoma: Their relationship with clinicopathological parameters and prognostic significance.1 passage
• Downregulation of long non-coding RNAs JPX and XIST is associated with the prognosis of hepatocellular carcinoma.1 passage
• Drastic decrease of urgent endoscopies outside regular working hours during the Covid-19 pandemic in the paris area.1 passage
• Drug-eluting bead transarterial chemoembolization (TACE) exhibits superior efficacy and equal tolerance to conventional TACE in hepatocellular carcinoma patients with conventional TACE history.1 passage
• Drug-eluting bead transarterial chemoembolization is an effective downstaging option for subsequent radical treatments in patients with hepatocellular carcinoma: A cohort study.1 passage
• Duration from the first pale stool to portoenterostomy is prognostic in biliary atresia. Comparison with age at portoenterostomy.1 passage
• Duration of combination therapy and risk of treatment failure in patients with inflammatory bowel disease.1 passage
• Early acute kidney injury after liver transplantation in patients with normal preoperative renal function.1 passage
• Early esophageal signet ring cell carcinoma: A contraindication to endoscopic resection?1 passage
• Early high levels of regulatory T cells and T helper 1 may predict the progression of recurrent hepatitis C after liver transplantation.1 passage
• Early onset lysosomal acid lipase deficiency presenting as secondary hemophagocytic lymphohistiocytosis: Two infants treated with sebelipase alfa.1 passage
• Early virological assessment during telaprevir- or boceprevir-based triple therapy in hepatitis C cirrhotic patients who failed a previous interferon based regimen - The ANRS CO20-CUPIC study.1 passage
• Early, short-term, low-dose glucocorticoid therapy effectively blocks progression of severe acute exacerbation of chronic hepatitis B to liver failure.1 passage
• Effect of N-acetylcysteine on remission maintenance in patients with ulcerative colitis: A randomized, double-blind controlled clinical trial.1 passage
• Effect of ceramide-1-phosphate transfer protein on intestinal bacterial translocation in severe acute pancreatitis.1 passage
• Effect of implementing a regional referral network on surgical referral rate of benign polyps found during a colorectal cancer screening program: A population-based study.1 passage
• Effect of intestinal epithelial autophagy on bacterial translocation in severe acute pancreatitis.1 passage
• Effect of liraglutide therapy on serum fetuin A in patients with type 2 diabetes and non-alcoholic fatty liver disease.1 passage
• Effect of mycophenolic acid on inosine monophosphate dehydrogenase (IMPDH) activity in liver transplant patients.1 passage
• Effect of proton pump inhibitors in hospitalization on mortality of patients with hepatic encephalopathy and cirrhosis but no active gastrointestinal bleeding.1 passage
• Effectiveness and safety of biologics in pediatric inflammatory boweldisease: Real-life data from the Sicilian Network.1 passage
• Effects of caffeine consumption in patients with chronic hepatitis C: A systematic review and meta-analysis.1 passage
• Effects of miR-339-5p on invasion and prognosis of hepatocellular carcinoma.1 passage
• Effects of odevixibat on pruritus and bile acids in children with cholestatic liver disease: Phase 2 study.1 passage
• Effects of preventive versus "on-demand" nutritional support on paid labour productivity, physical exercise and performance status during PEG-interferon-containing treatment for hepatitis C.1 passage
• Efficacy and safety of acetylcysteine in "non-acetaminophen" acute liver failure: A meta-analysis of prospective clinical trials.1 passage
• Efficacy and safety of anticoagulants in liver cirrhosis patients with portal vein thrombosis: A meta-analysis.1 passage
• Efficacy and safety of boceprevir-based triple therapy in HCV cirrhotic patients awaiting liver transplantation (ANRS HC29 BOCEPRETRANSPLANT).1 passage
• Efficacy and safety of carbon dioxide insufflation versus air insufflation for endoscopic retrograde cholangiopancreatography: A meta-analysis update.1 passage
• Efficacy and safety of endoscopic submucosal dissection for large gastric stromal tumors.1 passage
• Efficacy and safety of glucagon-like peptide-1 receptor agonists in non-alcoholic fatty liver disease: A systematic review and meta-analysis.1 passage
• Efficacy and safety of islet autotransplantation after total pancreatectomy in chronic pancreatitis: A systematic review and meta-analysis including 17 studies.1 passage
• Efficacy and safety of obeticholic acid in liver disease-A systematic review and meta-analysis.1 passage
• Efficacy and safety of photodynamic therapy for unresectable cholangiocarcinoma: A meta-analysis.1 passage
• Efficacy and safety of simeprevir for chronic hepatitis virus C genotype 1 infection: A meta-analysis.1 passage
• Efficacy and safety of transarterial chemoembolization plus sorafenib for early or intermediate stage hepatocellular carcinoma: A systematic review and meta-analysis of randomized controlled trials.1 passage
• Efficacy of antiviral therapy with nucleotide/nucleoside analogs after curative treatment for patients with hepatitis B virus-related hepatocellular carcinoma: A systematic review and meta-analysis.1 passage
• Efficacy of entecavir treatment for up to 96 weeks in nucleoside-naive HBeAg-positive chronic hepatitis B patients with high viral load.1 passage
• Efficacy of intravenous immunoglobulin therapy in giant cell hepatitis with autoimmune hemolytic anemia: A multicenter study.1 passage
• Efficacy of ombitasvir/paritaprevir/ritonavir/ribavirin in management of HCV genotype 4 and end-stage kidney disease.1 passage
• Efficacy of statins in treatment and development of non-alcoholic fatty liver disease and steatohepatitis: A systematic review and meta-analysis.1 passage
• Efficacy of tenofovir-based rescue therapy in patients with lamivudine-resistant hepatitis B virus: A systematic review and meta-analysis.1 passage
• Elevated LINC01232 is associated with poor prognosis and HBV infection in hepatocellular carcinoma patients and contributes to tumor progression in vitro.1 passage
• Elevated lactate impairs the efficacy of antiviral treatment on post-hepatectomy survival for advanced stage hepatitis B virus - related hepatocellular carcinoma.1 passage
• Elevated mean platelet volume is associated with poor short-term outcomes in hepatitis B virus-related acute-on-chronic liver failure patients.1 passage
• Elevated preoperative CA125 levels predicts poor prognosis of hilar cholangiocarcinoma receiving radical surgery.1 passage
• Endoscopic "rescue" treatment for gastrointestinal perforations, anastomotic dehiscence and fistula.1 passage
• Endoscopic balloon dilation of colorectal strictures complicating Crohn's disease: a multicenter study.1 passage
• Endoscopic resection versus esophagectomy for patients with small-sized T1N0 esophageal cancer: A propensity-matched study.1 passage
• Endoscopic stenting as bridge-to-surgery (BTS) in left-sided obstructing colorectal cancer: Experience with conformable stents.1 passage
• Endoscopic training: A nationwide survey of French fellows in gastroenterology.1 passage
• Endoscopic ultrasound in pancreatic cancer treatment: Facts and hopes.1 passage
• Enhancing digestive fistula healing by the off-label use of a thermoresponsive vessel occluder polymer associated with esophageal stent placement: A case report.1 passage
• Eosinophilic colitis in adults.1 passage
• Epidemiology of Budd-Chiari syndrome: A systematic review and meta-analysis.1 passage
• Epidemiology of Cholangiocarcinoma; United States Incidence and Mortality Trends.1 passage
• Epidemiology of HBV subgenotypes D.1 passage
• Epidemiology of hepatitis C virus infection.1 passage
• Epigenetic regulation of liver fibrosis.1 passage
• Epstein-Barr virus negative smooth muscle neoplasm of the stomach in a young woman.1 passage
• Epstein-Barr virus-negative inflammatory pseudotumor-like variant of follicular dendritic cell sarcoma of the liver: A case report and literature review.1 passage
• Estrogen receptor 1 (ESR1) genetic variations in cancer risk: a systematic review and meta-analysis.1 passage
• Evaluation of a combinational use of serum microRNAs as biomarkers for liver diseases.1 passage
• Evaluation of drug-eluting beads versus conventional transcatheter arterial chemoembolization in patients with unresectable hepatocellular carcinoma: A systematic review and meta-analysis.1 passage
• Evaluation of efficacy, safety and treatment-related outcomes of percutaneous radiofrequency ablation versus partial hepatectomy for small primary liver cancer meeting the Milan criteria: A systematic review and meta-analysis of randomized controlled trials.1 passage
• Evaluation of endothelial dysfunction in patients with nonalcoholic fatty liver disease: Association of selenoprotein P with carotid intima-media thickness and endothelium-dependent vasodilation.1 passage
• Evaluation of miR-331-3p and miR-23b-3p as serum biomarkers for hepatitis c virus-related hepatocellular carcinoma at early stage.1 passage
• Evaluation of microRNAs-29a, 92a and 145 in colorectal carcinoma as candidate diagnostic markers: An Egyptian pilot study.1 passage
• Evaluation of mid- and long-term efficacy of shunt limiting for hepatic myelopathy after transjugular intrahepatic portosystemic shunt.1 passage
• Evaluation of vitamin D status bone mineral density and dental health in children with cholestasis.1 passage
• Evolution of diagnostic criteria for acute kidney injury in patients with decompensated cirrhosis: A prospective study in a tertiary university hospital.1 passage
• Expectations of IBS patients concerning disease and healthcare providers: Results of a prospective survey among members of a French patients' association.1 passage
• Experience with the use of a hemostatic powder in 152 patients undergoing urgent endoscopy for gastrointestinal bleeding.1 passage
• Expression and prognostic value of HER-2/neu, STAT3 and SOCS3 in hepatocellular carcinoma.1 passage
• Expression and significance of peripheral myeloid-derived suppressor cells in chronic hepatitis B patients.1 passage
• Extended duration versus standard duration of peginterferon alfa-2a in treatment of chronic hepatitis B: A systematic review and meta-analysis.1 passage
• Extrahepatic biliary duplication with heterotopic gastric mucosa in a 46,XX male patient.1 passage
• FXR: Big fish or small fry for drug-induced liver injury?1 passage
• Factors associated with non adherence to a gluten free diet in adult with celiac disease: A survey assessed by BIAGI score.1 passage
• Feasibility of domino liver transplantation from hyperhomocsyteinemia.1 passage
• Features and outcomes from a retrospective study of 570 hospitalized Chinese patients with drug-induced liver injury.1 passage
• Fenofibrate is effective adjunctive therapy in the treatment of primary biliary cirrhosis: A meta-analysis.1 passage
• Fenofibrate-induced massive regression of mutiple inflammatory hepatocellular adenoma.1 passage
• Fetal coenzyme Q10 deficiency in intrahepatic cholestasis of pregnancy.1 passage
• First case of serrated lesion of the duodenal papilla in a patient with serrated colonic polyposis.1 passage
• Flap endonuclease 1 (FEN1) as a novel diagnostic and prognostic biomarker for gastric cancer.1 passage
• Focal Adhesion Kinase: A promising therapeutic target in pancreatic adenocarcinoma.1 passage
• For colorectal cancer patients with type II diabetes, could metformin improve the survival rate? A meta-analysis.1 passage
• Frailty, sarcopenia and mortality in cirrhosis: what is the best assessment, how to interpret the data correctly and what interventions are possible?1 passage
• Fumarate hydratase-specific T cell response in Chinese patients with autoimmune hepatitis.1 passage
• Functional miR-146a, miR-149, miR-196a2 and miR-499 polymorphisms and the susceptibility to hepatocellular carcinoma: An updated meta-analysis.1 passage
• Gammadelta T cells as a predictor of surgical relapse of Crohn's disease.1 passage
• Gastrointestinal bleeding from vascular malformations: Is octreotide effective to rescue difficult-to-treat patients?1 passage
• Gastrointestinal stromal tumors (GIST) presenting in the liver: Diagnostic, prognostic and therapeutic issues.1 passage
• Gastrointestinal, hepatic and pancreatic manifestations of COVID-19 in children.1 passage
• Gender differences in liver fibrosis among patients younger than 50 years: A retrospective cohort study.1 passage
• Genetic polymorphism of fibroblast growth factor receptor 2 and trinucleotide repeat-containing 9 influence the susceptibility to HCV-induced hepatocellular carcinoma.1 passage
• Genetic polymorphisms and oxidative stress in non-alcoholic steatohepatitis (NASH): A mini review.1 passage
• Genetic variant of TMBIM1 is associated with the susceptibility of colorectal cancer in the Chinese population.1 passage
• Genetic variants in glucose-6-phosphate isomerase gene as prognosis predictors in hepatocellular carcinoma.1 passage
• Genetic variants of mannose-binding lectin 2 gene influence progression and prognosis of patients with hepatitis B virus infection in China.1 passage
• Genetic variants of the DNA damage repair genes XRCC4 and RAD51 are associated with susceptibility to esophageal cancer.1 passage
• Genetic variations of mitochondrial genome modify risk and prognosis of hepatocellular carcinoma patients.1 passage
• Growth differentiation factor 15 promotes cell viability, invasion, migration, and angiogenesis in human liver carcinoma cell line HepG2.1 passage
• Gut microbiota and hypertension: From pathogenesis to new therapeutic strategies.1 passage
• Gut microbiota in PSC : From association to possible causality. Commentary to "Gut pathobionts underlie intestinal barrier dysfunction and liver T helper 17 cell immune response in primary sclerosing cholangitis" by Nakamoto et al., Nature Microbiology, January 2019.1 passage
• HBV vaccination with Fendrix is effective and safe in pre-dialysis CKD population.1 passage
• HBV-infection rate and long-term outcome after liver-transplantation of anti-HBc-positive liver-grafts to HBV-naïve recipients: A retrospective study.1 passage
• HCV virology and diagnosis.1 passage
• HER2/neu over-expression predicts poor outcome in early gastric cancer without lymph node metastasis.1 passage
• HLA matching and rabbit antithymocyte globulin as induction therapy to avoid multiple forms of rejection after a third liver transplantation.1 passage
• Health-related quality of life in pre-adolescent liver transplant recipients with biliary atresia: A cross-sectional study.1 passage
• Helicobacter pylori in celiac disease and in duodenal intraepithelial lymphocytosis: Active protagonist or innocent bystander?1 passage
• Helicobacter pylori infection: association with dietary habits and socioeconomic conditions.1 passage
• Hepatic glycogen deposition in a patient with anorexia nervosa and persistently abnormal transaminase levels.1 passage
• Hepatic perivascular epithelioid tumor (PEComa). A case report.1 passage
• Hepatitis B virus American genotypes: Pathogenic variants ?1 passage
• Hepatitis B virus is associated with the clinical features and survival rate of patients with intrahepatic cholangiocarcinoma.1 passage
• Hepatitis B virus reactivation recurred after the cessation of entecavir in an allogenetic hematopoietic stem cell transplantation patient.1 passage
• Hepatitis C infection and intrahepatic cholestasis of pregnancy: A systematic review and meta-analysis.1 passage
• Hepatitis C standards of care: A review of good practices since the advent of direct-acting antiviral therapy.1 passage
• Hepatitis C virus and atherosclerosis: A legacy after virologic cure?1 passage
• Hepatitis C virus and mortality among patients on dialysis: A systematic review and meta-analysis.1 passage
• Hepatitis C virus-related vasculitis.1 passage
• Hepatitis Delta recurrence post-liver transplantation in absence of detectable hepatitis B surface antigen and hepatitis B virus DNA in peripheral blood.1 passage
• Hepatitis E virus infection mimicking acute graft rejection in a liver transplant recipient.1 passage
• Hepatitis E virus: chronic infection, extra-hepatic manifestations, and treatment.1 passage
• Hepatitis during pregnancy: A case of hemophagocytic lymphohistiocytosis.1 passage
• Hepatocellular adenoma management: call for shared guidelines and multidisciplinary approach.1 passage
• Hepatocellular carcinoma suppressor 1 promoter hypermethylation in serum. A diagnostic and prognostic study in hepatitis B.1 passage
• Hepatocellular carcinoma: French Intergroup Clinical Practice Guidelines for diagnosis, treatment and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, AFEF, SIAD, SFR/FRI).1 passage
• Hepatotoxicity of iodine-131 ablation for post-surgical differentiated thyroid cancer patients with hepatitis B virus infection.1 passage
• Hereditary diffuse gastric cancer (HDGC). An overview.1 passage
• Hereditary hemorrhagic telangiectasia and liver involvement: Vascular liver diseases: position papers from the francophone network for vascular liver diseases, the French Association for the Study of the Liver (AFEF), and ERN-rare liver.1 passage
• High expression of Beclin-1 predicts favorable prognosis for patients with colorectal cancer.1 passage
• High expression of TRIM11 correlates with poor prognosis in patients with hepatocellular carcinoma.1 passage
• Higher PKD3 expression in hepatocellular carcinoma (HCC) tissues predicts poorer prognosis for HCC patients.1 passage
• Higher tumor protein kinase D1 correlates with increased tumor size, BCLC stage, CA199 level, AFP level and worse overall survival in hepatocellular carcinoma patients.1 passage
• Histological inflammation in ulcerative colitis in deep remission under treatment with infliximab.1 passage
• Histopathological expression of Yes-associated protein in neonatal cholestasis.1 passage
• How does comorbidity affect colon cancer patients' care trajectory? Results from the French EvaCCoR cohort study.1 passage
• How will NAFLD change the liver transplant landscape in the 2020s?1 passage
• Hydrochlorothiazide-induced hepatotoxicity: A rare case of DILI.1 passage
• Hydrogen-rich water reduces liver fat accumulation and improves liver enzyme profiles in patients with non-alcoholic fatty liver disease: a randomized controlled pilot trial.1 passage
• IL28B rs12980275 variant as a predictor of sustained virologic response to pegylated-interferon and ribavirin in chronic hepatitis C patients: A systematic review and meta-analysis.1 passage
• Identification of microRNAs as biomarkers for cholangiocarcinoma detection: A diagnostic meta-analysis.1 passage
• Identification of plasma miR-148a as a noninvasive biomarker for hepatocellular carcinoma.1 passage
• Identification of the transcriptional regulators by expression profiling infected with hepatitis B virus.1 passage
• IgG4 disease: The great masquerader.1 passage
• Imaging modalities for the diagnosis of hepatic fibrosis and cirrhosis.1 passage
• Immature platelet fraction values predict recovery of platelet counts following liver transplantation.1 passage
• Immune checkpoint inhibitor induced colitis: A nationwide population-based study.1 passage
• Immune dysregulation in Alagille syndrome: A new feature of the evolving phenotype.1 passage
• Immunosuppressive regimen and risk for de novo malignancies after liver transplantation for alcoholic liver disease.1 passage
• Impact of COVID-19 Pandemic on Gastrointestinal Cancer Diagnosis and Resection: An Observational Study.1 passage
• Impact of early remote organ dysfunction on long-term survival after liver transplantation.1 passage
• Impact of graft preservation solutions for liver transplantation on early cytokine release and postoperative organ dysfunctions. A pilot study.1 passage
• Impact of hepatic immunoreactivity of angiotensin-converting enzyme 2 on liver fibrosis due to non-alcoholic steatohepatitis.1 passage
• Impact of metformin use on risk and mortality of hepatocellular carcinoma in diabetes mellitus.1 passage
• Impact of sarcopenia on clinical outcomes of patients undergoing simultaneous liver and kidney transplantation: a cohort study.1 passage
• Impact of the first Covid-19 outbreak on liver transplantation activity in France: A snapshot.1 passage
• Impact of vascular liver disease on the menstrual cycle and metabolic status in premenopausal women.1 passage
• Impaired expression and function of TLR8 in chronic HBV infection and its association with treatment responses during peg-IFN-α-2a antiviral therapy.1 passage
• Improved quantitative assessment of HBV-associated liver fibrosis using second-harmonic generation microscopy with feature selection.1 passage
• Improved survival of cirrhotic patients with variceal bleeding over the decade 2000-2010.1 passage
• In vitro high-throughput drug sensitivity screening with patient-derived primary cells as a guide for clinical practice in hepatocellular carcinoma-A retrospective evaluation.1 passage
• Incidence and characteristics of young-onset colorectal cancer in the United States: An analysis of SEER data collected from 1988 to 2013.1 passage
• Increased incidence of Campylobacter enteritis and their quinolone resistance between 2010 and 2015: Results of a French national observatory conducted in 21 general hospitals (CHG).1 passage
• Increased mortality in non-alcoholic fatty liver disease with chronic kidney disease is explained by metabolic comorbidities.1 passage
• Increased sTREM-1 levels identify cirrhotic patients with bacterial infection and predict their 90-day mortality.1 passage
• Individuals affected by eosinophilic gastrointestinal disorders have complex unmet needs and frequently experience unique barriers to care.1 passage
• Induced pluripotent stem cells: An unlimited source of organs for transplantation.1 passage
• Inflammasome activation in the liver: Focus on alcoholic and non-alcoholic steatohepatitis.1 passage
• Inflammatory bowel disease in Shwachman-Diamond syndrome; is there an association?1 passage
• Inflammatory bowel disease symptoms at the time of anal fistula lead to the diagnosis of Crohn's disease.1 passage
• Influence of aspirin use on clinical outcomes of patients with hepatocellular carcinoma: a meta-analysis.1 passage
• Influence of everolimus-based treatment on circulating regulatory T cells after liver transplantation: Comparative study with tacrolimus-based therapy.1 passage
• Inhibition of USP11 sensitizes gastric cancer to chemotherapy via suppressing RhoA and Ras-mediated signaling pathways.1 passage
• Inhibition of β-glucosidase overcomes gastric cancer chemoresistance through inducing lysosomal dysfunction.1 passage
• Input of serum haptoglobin fucosylation profile in the diagnosis of hepatocellular carcinoma in patients with non-cirrhotic liver disease.1 passage
• Integrated expression profiles of mRNA and miRNA in a gerbil model of fatty liver fibrosis treated with exenatide.1 passage
• Interleukin 22 is related to development and poor prognosis of hepatocellular carcinoma.1 passage
• Interleukin-10 promoter gene polymorphisms are associated with the first major depressive episode in chronic hepatitis C patients.1 passage
• Interleukin-23 receptor genetic polymorphisms and ulcerative colitis susceptibility: A meta-analysis.1 passage
• Interleukin-35: An emerging player in the progression of liver diseases.1 passage
• Interplay of Wnt β-catenin pathway and miRNAs in HBV pathogenesis leading to HCC.1 passage
• Interventional oncology for hepatocellular carcinoma.1 passage
• Intraabdominal urokinase in the treatment of loculated infected ascites in cirrhosis.1 passage
• Intrahepatic cholestasis of pregnancy in conjunction with a frameshift deletion in FGFR4.1 passage
• Intrahepatic cholestasis of pregnancy: A risk factor for cancer, autoimmune and cardiovascular diseases?1 passage
• Inverted colonic diverticulum (ICD): report of two cases and literature review of a not that unusual endoscopic challenge.1 passage
• Is it necessary to perform a morphological assessment for an esophageal motility disorder? A retrospective descriptive study.1 passage
• Is minimally invasive true anatomical HCC resection a future way to improve results in bridge or salvage liver transplantation?1 passage
• Is survival for hepatocellular carcinoma increasing? A population-based study on survival of hepatocellular carcinoma patients in the 1990s and 2000s.1 passage
• Is targeting autophagy a promising lead to unveil the cloak of invisibility in pancreatic cancer?1 passage
• Is within-normal range liver enzymes associated with metabolic syndrome in adults?1 passage
• Ischemic-type biliary lesions: A leading indication of liver retransplantation with excellent results.1 passage
• Isolated hepatic tuberculosis in the caudate lobe mimicking intrahepatic carcinoma.1 passage
• LGR5, a relevant marker of cancer stem cells, indicates a poor prognosis in colorectal cancer patients: a meta-analysis.1 passage
• LUM is the hub gene of advanced fibrosis in nonalcoholic fatty liver disease patients.1 passage
• Laparoscopic versus open gastrectomy for advanced gastric cancer: A meta-analysis based on high-quality retrospective studies and clinical randomized trials.1 passage
• Larazotide acetate for treatment of celiac disease: A systematic review and meta-analysis of randomized controlled trials.1 passage
• Learning curve and intra/interobserver agreement of transient elastography in chronic hepatitis C patients with or without HIV co-infection.1 passage
• Life expectancy in pancreatic neuroendocrine cancer.1 passage
• Liraglutide in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis of randomized controlled trials.1 passage
• Liver and kidney function in refractory heart failure: The narrow gate to achieve post-transplant survival.1 passage
• Liver failure after long-limb gastric bypass.1 passage
• Liver fibrosis staging by computed tomography: Prospective randomized multicentric evaluation of image analyses.1 passage
• Liver fibrosis: Common mechanisms and antifibrotic therapies.1 passage
• Liver function test abnormalities are associated with a poorer prognosis in Covid-19 patients: Results of a French cohort.1 passage
• Liver health literacy and social stigma of liver disease: A general population e-survey.1 passage
• Liver immunology: How to reconcile tolerance with autoimmunity.1 passage
• Liver physiological polyploidization: MicroRNA-122 a key regulator.1 passage
• Liver stiffness as measured by two-dimensional shear wave elastography overestimates the stage of fibrosis in patients with chronic hepatitis B and hepatic steatosis.1 passage
• Liver transarterial chemoembolization and sunitinib for unresectable hepatocellular carcinoma: Results of the PRODIGE 16 study.1 passage
• Liver transplantation for critically ill cirrhotic patients: results from the French transplant registry.1 passage
• Liver transplantation in adults with portal vein thrombosis: Data from the China Liver Transplant Registry.1 passage
• LncRNA SLC16A1-AS1 is upregulated in hepatocellular carcinoma and predicts poor survival.1 passage
• Local treatment of pancreatic cancer metastases: A multicenter French study of the AGEO group.1 passage
• Long non-coding RNA 01559 mediates the malignant phenotypes of hepatocellular carcinoma cells through targeting miR-511.1 passage
• Long non-coding RNA LINC00472 suppresses hepatocellular carcinoma cell proliferation, migration and invasion through miR-93-5p/PDCD4 pathway.1 passage
• Long non-coding RNA MBNL1-AS1 regulates proliferation, migration, and invasion of cancer stem cells in colon cancer by interacting with MYL9 via sponging microRNA-412-3p.1 passage
• Long noncoding RNA PVT1 promotes tumour progression via the miR-128/ZEB1 axis and predicts poor prognosis in esophageal cancer.1 passage
• Long-term disease course in a patient with severe neonatal IPEX syndrome.1 passage
• Long-term outcome of patients with difficult-to-treat autoimmune hepatitis receiving mycophenolate mofetil.1 passage
• Long-term results of pediatric liver transplantation for autoimmune liver disease.1 passage
• Longitudinal monitoring of liver stiffness by acoustic radiation force impulse imaging in patients with chronic hepatitis B receiving entecavir.1 passage
• Low levels of Lysosomal Acid Lipase (LAL) activity increases necroinflammation in adult patients with biopsy-proven metabolic associated fatty liver disease.1 passage
• Low levels of circulating microRNA-26a/29a as poor prognostic markers in patients with hepatocellular carcinoma who underwent curative treatment.1 passage
• Low prevalence of dysplastic polyps in patients with ulcerative colitis.1 passage
• Low serum alkaline phosphatase levels in patients with chronic liver diseases: Possible contributions to disease pathogenesis.1 passage
• Low urine pH is a risk for non-alcoholic fatty liver disease: A population-based longitudinal study.1 passage
• Lower number and decreased function of natural killer cells in hepatitis B virus related acute-on-chronic liver failure.1 passage
• Lymphogenous metastasis to the transverse colon that originated from signet-ring cell gastric cancer: A case report and review of the literature.1 passage
• Magnetic resonance cholangiography: Current and future perspectives.1 passage
• Management of HCV in the liver transplant setting.1 passage
• Management of alcohol recurrence before and after liver transplantation.1 passage
• Management of anticoagulation in adult patients with chronic parenchymal or vascular liver disease: Vascular liver diseases: Position papers from the francophone network for vascular liver diseases, the French Association for the Study of the Liver (AFEF), and ERN-rare liver.1 passage
• Management of colon cancer patients: A comprehensive analysis of the absence of multidisciplinary team meetings in two French departments.1 passage
• Management of difficult or failed biliary access in initial ERCP: A review of current literature.1 passage
• Management of infections in patients with cirrhosis in the context of increasing therapeutic resistance: A systematic review.1 passage
• Management of portal cavernoma-associated cholangiopathy: Single-centre experience.1 passage
• Marital status is an independent prognostic factor for pancreatic neuroendocrine tumors patients: An analysis of the Surveillance, Epidemiology, and End Results (SEER) database.1 passage
• Marked coagulopathy without liver disease or anticoagulation therapy.1 passage
• Marked edema of colonic stoma after colectomy and severe pulmonary hypertension: Report of two cases.1 passage
• Measure grip strength, gait speed and quadriceps muscle in cirrhosis. Comment to "Frailty, sarcopenia and mortality in cirrhosis: What is the best assessment, how to interpret the data correctly and what interventions are possible?"1 passage
• Meta-analysis of the association between MBOAT7 rs641738, TM6SF2 rs58542926 and nonalcoholic fatty liver disease susceptibility.1 passage
• Metabolic iron disorder after liver transplant: Hereditary hemochromatosis in a pediatric recipient of a pediatric donor with unknown HFE C282Y homozygous mutation.1 passage
• Metabolic syndrome and colorectal adenoma risk: A systematic review and meta‑analysis.1 passage
• Metabolically healthy and unhealthy obesity and the progression of liver fibrosis: A cross-sectional study.1 passage
• Metastases of pancreatic neuroendocrine tumor to the liver as extremely rare indication for liver transplantation in children. Case report and review of the literature.1 passage
• Metformin and everolimus in neuroendocrine tumours: A synergic effect?1 passage
• Methylation of promoter and expression silencing of GPX3 gene in hepatocellular carcinoma tissue.1 passage
• Methylprednisolone liver toxicity: A new case and a French regional pharmacovigilance survey.1 passage
• Methylprednisolone-related liver injury: A descriptive study using the French pharmacovigilance database.1 passage
• MiR-142 suppresses progression of gastric carcinoma via directly targeting LRP8.1 passage
• MiR-146a rs2910164 polymorphism increases the risk of digestive system cancer: A meta-analysis.1 passage
• MicroRNA-126-5p suppresses cell proliferation, invasion and migration by targeting EGFR in liver cancer.1 passage
• MicroRNA-200c expression is decreased in hepatocellular carcinoma and associated with poor prognosis.1 passage
• MicroRNA-214 promotes peritoneal metastasis through regulating PTEN negatively in gastric cancer.1 passage
• MicroRNAs as biomarkers for hepatocellular carcinoma diagnosis and prognosis.1 passage
• MicroRNAs in cholangiopathies: Potential diagnostic and therapeutic tools.1 passage
• Microbiome and pancreatic ductal adenocarcinoma.1 passage
• Microvascular invasion and positive HB e antigen are associated with poorer survival after hepatectomy of early hepatocellular carcinoma: A retrospective cohort study.1 passage
• Mobile app requirements for patients with rare liver diseases: A single center survey for the ERN RARE-LIVER‬‬‬.1 passage
• Modified AST to platelet ratio index improves APRI and better predicts advanced fibrosis and liver cirrhosis in patients with non-alcoholic fatty liver disease.1 passage
• Molecular bases of the poor response of liver cancer to chemotherapy.1 passage
• Morphogen-related therapeutic targets for liver fibrosis.1 passage
• Mus81 knockdown sensitizes colon cancer cells to chemotherapeutic drugs by activating CHK1 pathway.1 passage
• Muscle mass depletion in chronic liver diseases: An accelerated model of aging or a distinct entity?1 passage
• Mutations in basal core promoter is associated with significant fibrosis in both HBeAg positive and negative treatment-naïve chronic hepatitis B.1 passage
• Myosteatosis in nonalcoholic fatty liver disease: An exploratory study.1 passage
• Myxoid hepatocellular adenoma, a rare variant of hepatocellular adenoma with distinct imaging features: A case report with immunohistochemical and molecular analysis and literature review.1 passage
• Ménétrier's disease: Long-term remission with lanreotide.1 passage
• NON-INVASIVE DIAGNOSIS AND FOLLOW-UP OF CHRONIC INFECTION WITH HEPATITIS B VIRUS.1 passage
• NON-INVASIVE DIAGNOSIS AND FOLLOW-UP OF PORTAL HYPERTENSION.1 passage
• NTCP deficiency: a new inherited disease of bile acid transport.1 passage
• Naturally occurring NS5A and NS5B resistant associated substitutions in HCV and HCV/HIV patients in iranian population.1 passage
• Negative wound therapy to manage large-for-size liver graft mismatch.1 passage
• Neonatal cholestasis and Niemann-pick type C disease: A literature review.1 passage
• Neutrophil extracellular traps induced by pro-inflammatory cytokines enhance procoagulant activity in NASH patients.1 passage
• New molecular therapies for hepatocellular carcinoma.1 passage
• New therapies for hepatic fibrosis.1 passage
• Nitroglycerine use in transcatheter arterial (chemo) embolization in patients with hepatocellular carcinoma: Five-year retrospective study.1 passage
• Non-Alcoholic Fatty Liver Disease in Non-Obese Individuals: Prevalence, Pathogenesis and Treatment.1 passage
• Non-alcoholic fatty liver disease (NAFLD) and 10-year risk of cardiovascular diseases.1 passage
• Non-alcoholic fatty liver disease and flavonoids: Current perspectives.1 passage
• Non-alcoholic fatty liver disease causes dissociated changes in metabolic liver functions.1 passage
• Non-coding RNAs as biomarkers for hepatocellular carcinoma-A systematic review.1 passage
• Non-coding RNAs open a new chapter in liver cancer treatment.1 passage
• Non-invasive assessment of fibrosis and steatosis in pediatric non-alcoholic fatty liver disease.1 passage
• Non-invasive diagnosis and follow-up in liver transplantation.1 passage
• Non-invasive diagnosis and follow-up of autoimmune hepatitis.1 passage
• Non-invasive diagnosis and follow-up of benign liver tumours.1 passage
• Non-invasive diagnosis and follow-up of chronic infection with Hepatitis C Virus.1 passage
• Non-invasive diagnosis and follow-up of hyperferritinaemia.1 passage
• Non-invasive diagnosis and follow-up of non-alcoholic fatty liver disease.1 passage
• Non-invasive diagnosis and follow-up of primary biliary cholangitis.1 passage
• Non-invasive diagnosis and follow-up of primary malignant liver tumours.1 passage
• Non-invasive diagnosis and follow-up of primary sclerosing cholangitis.1 passage
• Non-invasive diagnosis and follow-up of rare genetic liver diseases.1 passage
• Non-invasive diagnosis and follow-up of vascular liver diseases.1 passage
• Non-invasive fibrosis tests to predict complications in compensated post-hepatitis C cirrhosis.1 passage
• Non-small-bowel lesions identification by capsule endoscopy: A single centre retrospective study.1 passage
• Nonalcoholic fatty liver disease (NAFLD) without insulin resistance: Is it different?1 passage
• Noninvasive diagnosis of liver fibrosis in NAFLD: Tips tricks.1 passage
• Notch signaling and M1 macrophage activation in obesity-alcohol synergism.1 passage
• Novel albumin, bilirubin and platelet criteria for the exclusion of high-risk varices in compensated advanced chronic liver disease: A validation study.1 passage
• Novel predictive models using serum ceruloplasmin levels for hepatic steatosis in patients with chronic hepatitis B infection.1 passage
• Novel therapeutic targets for steatohepatitis.1 passage
• Number and function of circulating endothelial progenitor cells in patients with primary Budd-Chiari syndrome.1 passage
• Nurse coordinator roles in the management of patients with hepatocellular carcinoma: A French national survey.1 passage
• Obesity, dynapenia and high cardiovascular risk co-exist in post-liver transplant setting: results of a cross-sectional study.1 passage
• Obeticholic acid in primary biliary cholangitis.1 passage
• Obstructed membranous transformation of the inferior vena cava in patients with hepatic vein-type Budd-Chiari syndrome: A case series.1 passage
• On hepatocellular carcinoma in South America and early-age onset of the disease.1 passage
• One-step percutaneous transhepatic cholangioscopic lithotripsy in patients with choledocholithiasis.1 passage
• Online training on how to diagnose anoperineal lesions of Crohn's disease: Do pictures matter? A nationwide randomized study.1 passage
• Optimization of the transition process of youth with liver disease in adulthood: A position paper from FILFOIE, the French network for paediatric and adult rare liver diseases.1 passage
• Optimizing patient referral and center capacity in the management of chronic hepatitis C: Lessons from the Italian experience.1 passage
• Oral ibuprofen promoted cholestatic liver disease in very low birth weight infants with patent ductus arteriosus.1 passage
• Osteopathic management of chronic constipation in women patients. Results of a pilot study.1 passage
• Outcome after pancreatectomy for neuroendocrine neoplams according to the WHO 2017 grading system: A retrospective multicentric analysis of 138 consecutive patients.1 passage
• Outcome of the use of paediatric donor livers in adult recipients: A single Chinese centre experience.1 passage
• Outcomes of endoscopic submucosal dissection for early esophageal and gastric cardia adenocarcinomas.1 passage
• Over 90% of cases of Microscopic Colitis can be diagnosed by performing a short colonoscopy.1 passage
• Overexpression of CSN6 promotes the epithelial-mesenchymal transition and predicts poor prognosis in hepatocellular carcinoma.1 passage
• Overexpression of NEDD9 promotes cell invasion and metastasis in hepatocellular carcinoma.1 passage
• Overexpression of serum sST2 is associated with poor prognosis in acute-on-chronic hepatitis B liver failure.1 passage
• PARP inhibitors and radiation potentiate liver cell death in vitro. Do hepatocellular carcinomas have an achilles' heel?1 passage
• PKM2 upregulation promotes malignancy and indicates poor prognosis for intrahepatic cholangiocarcinoma.1 passage
• PPARγ gene Pro12Ala variants reduce the risk of obese individuals to non-alcoholic fatty liver: A study in Uygur Chinese population residing in Northwestern China.1 passage
• Palliation of malignant esophageal obstruction using an anti-migration self-expandable metal stent: Results of a prospective multicenter study.1 passage
• Pancreatic and gastric heterotopic tissue presenting as a symptomatic gallbladder mass: A case report and literature review.1 passage
• Pancreatic small cell cancer.1 passage
• Pancreatic stellate cells: A dynamic player of the intercellular communication in pancreatic cancer.1 passage
• Paraneoplastic fibrillary glomerulonephritis associated with intrahepatic cholangiocarcinoma: When diagnosis of a rare kidney disease leads to successful hepatic cancer treatment.1 passage
• Partial major hepatectomy with cyst fenestration for polycystic liver disease: Indications, short and long-term outcomes.1 passage
• Pathogenetic mechanisms of nonalcoholic fatty liver disease and inhibition of the inflammasome as a new therapeutic target.1 passage
• Pathophysiology and molecular mechanisms of liver injury in severe forms of COVID-19: An integrative review.1 passage
• Patient health utility, work productivity, and lifestyle impairment in chronic hepatitis C patients in France.1 passage
• Patient-reported tolerance in treatments approved in neuroendocrine tumors: A national survey from the French Group of Endocrine Tumors.1 passage
• Patterns of portosystemic collaterals and diameters of portal venous system in cirrhotic patients with hepatitis B on magnetic resonance imaging: Association with Child-Pugh classifications.1 passage
• Per-oral endoscopic myotomy for esophageal diverticula with or without esophageal motility disorders.1 passage
• Percutaneous ablation for locally advanced hepatocellular carcinoma with tumor portal invasion.1 passage
• Performance of serum HBcrAg in chronic hepatitis B patients with 8-year nucleos(t)ide analogs therapy.1 passage
• Performance of spleen stiffness measurement in prediction of clinical significant portal hypertension: A meta-analysis.1 passage
• Peripheral eosinophilia and hypoalbuminemia are associated with a higher biopsy diagnostic yield for eosinophilic gastroenteritis.1 passage
• Peroxisome-Related Genes in Hepatocellular Carcinoma Correlated with Tumor Metabolism and Overall Survival.1 passage
• Persisting hepatitis E virus infection leading to liver cirrhosis despite recovery of the immune system in an HIV-infected patient.1 passage
• Physical exercise in cirrhotic patients: Towards prehabilitation on waiting list for liver transplantation. A systematic review and meta-analysis.1 passage
• Plasma claudin-3 is associated with tumor necrosis factor-alpha-induced intestinal endotoxemia in liver disease.1 passage
• Polarized CD163+ tumor-associated macrophages are associated with increased angiogenesis and CXCL12 expression in gastric cancer.1 passage
• Polymorphism in the promoter region of lncRNA GAS5 is functionally associated with the risk of gastric cancer.1 passage
• Polymorphisms of HLA-DQB1 predict survival of hepatitis B virus-related hepatocellular carcinoma patients receiving hepatic resection.1 passage
• Population-based study of Entecavir and long-term mortality in chronic hepatitis B-related decompensated liver cirrhosis.1 passage
• Porphyrias: A 2015 update.1 passage
• Portable hemoglobinometer is a reliable technology for the follow-up of venesections tolerance in hemochromatosis.1 passage
• Portal cavernoma or chronic non cirrhotic extrahepatic portal vein obstruction.1 passage
• Portal hypertension with extensive fibrosis and plasma cell infiltration in multiple myeloma.1 passage
• Portal vein thrombosis and liver cirrhosis: Long-term anticoagulation is effective and safe.1 passage
• Portal vein thrombosis in cirrhosis is not associated with intestinal barrier disruption or increased platelet aggregability.1 passage
• Porto-sinusoidal vascular disease. Vascular liver diseases: Position papers from the francophone network for vascular liver diseases, the French Association for the Study of the Liver (AFEF), and ERN-rare liver.1 passage
• Positive histologic margins is a risk factor of recurrence after ileocaecal resection in Crohn's disease.1 passage
• Possible role of the HMGB1 and RAGE inflammatory pathway in primary sclerosing cholangitis.1 passage
• Postoperative antiviral therapy with nucleos(t)ide analogs for patients with hepatitis B virus-related hepatocellular carcinoma.1 passage
• Potential targeted therapies for the inflammatory pathogenesis of hepatic encephalopathy.1 passage
• Potentials of CRISPR in liver research and therapy.1 passage
• Practices and expectations on the use of circulating tumor DNA in colorectal cancer patients: A bi-national AGEO/AIOM/GERCOR/FFCD/FRENCH survey.1 passage
• Predictive criteria of response to endoscopic treatment for severe strictures in primary sclerosing cholangitis.1 passage
• Predictive factors for hepatocellular carcinoma in chronic hepatitis B using structural equation modeling: a prospective cohort study.1 passage
• Predictive factors for risk of hepatocellular carcinoma in immune inactive chronic hepatitis B.1 passage
• Predictive power of Interleukin-28B gene variants for outcome of Hepatitis C Virus genotype 4 in Egyptians: A systematic review and meta-analysis.1 passage
• Predictive value of liver damage for severe early complications and survival after heart transplantation: A retrospective analysis.1 passage
• Pregnancy and vascular liver diseases: Vascular liver diseases: position papers from the francophone network for vascular liver diseases, the French Association for the Study of the Liver (AFEF), and ERN-rare liver.1 passage
• Preoperative transarterial chemoembolization does not increase hepatic artery complications after liver transplantation: A single center 12-year experience.1 passage
• Present and future management of viral hepatitis B and C in children.1 passage
• Prevalence and clinical characteristics of alpha-1 antitrypsin deficiency in liver explants in a Mexican cohort.1 passage
• Prevalence and clinical features of hepatitis E virus infection in pregnant women: A large cohort study in Inner Mongolia, China.1 passage
• Prevalence and molecular characterization of hepatitis B virus infection in HIV-infected children in Senegal.1 passage
• Prevalence and prognosis of microsatellite instability in oesogastric adenocarcinoma, NORDICAP 16-01.1 passage
• Prevalence of baseline NS3 resistance-associated substitutions (RASs) on treatment with protease inhibitors in patients infected with HCV genotype 1.1 passage
• Primary biliary cholangitis in patients with inflammatory bowel disease.1 passage
• Primary hepatic angiosarcoma and liver transplantation: Radiological, surgical, histological findings and clinical outcome.1 passage
• Primary sclerosing cholangitis response to the combination of fibrates with ursodeoxycholic acid: French-Spanish experience.1 passage
• Prior surveillance and antiviral treatment improve the prognosis of HCC developed in HBV patients in the West.1 passage
• Proangiogenic factors in the development of HCC in alcoholic cirrhosis.1 passage
• Probe-based confocal laser endomicroscopy for the diagnosis of undetermined biliary stenoses: A meta-analysis.1 passage
• Probiotic bacteria, B. longum and L. acidophilus inhibit infection by rotavirus in vitro and decrease the duration of diarrhea in pediatric patients.1 passage
• Probiotics can improve the clinical outcomes of hepatic encephalopathy: An update meta-analysis.1 passage
• Probiotics in Helicobacter pylori eradication therapy: Systematic review and network meta-analysis.1 passage
• Profile of HBV polymerase gene mutations during entecavir treatment in patients with chronic hepatitis B.1 passage
• Prognosis of patients undergoing salvage TIPS is still poor in the preemptive TIPS era.1 passage
• Prognostic factors for survival after hepatic resection of early hepatocellular carcinoma in HBV-related cirrhotic patients.1 passage
• Prognostic value of MAGE-A9 expression in patients with colorectal cancer.1 passage
• Prognostic value of the early change in neutrophil-to-lymphocyte ratio in metastatic pancreatic adenocarcinoma.1 passage
• Promoter hypermethylation of TERT is associated with hepatocellular carcinoma in the Han Chinese population.1 passage
• Prophylactic lamivudine to improve the outcome of HBsAg-positive lymphoma patients during chemotherapy: a systematic review and meta-analysis.1 passage
• Prospective evaluation of third-generation small bowel capsule endoscopy videos by independent readers demonstrates poor reproducibility of cleanliness classifications.1 passage
• Psychosocial outcome and resilience after paediatric liver transplantation in young adults.1 passage
• Pulmonary infection after hepatic resection: associated factors and impact on outcomes.1 passage
• Quality criteria for the measurement of liver stiffness.1 passage
• Quality of life and illness perception in primary biliary cirrhosis: a controlled cross-sectional study.1 passage
• Quality of life in 1870 patients with constipation and/or fecal incontinence: Constipation should not be underestimated.1 passage
• Quantative HBsAg level correlates dendritic cells maturation in chronic hepatitis B patients.1 passage
• Radiofrequency ablation plus chemoembolization versus radiofrequency ablation alone for hepatocellular carcinoma: A systematic review and meta-analysis.1 passage
• Radiofrequency ablation versus resection for resectable liver metastases of gastrointestinal stromal tumours: Results from three national centres in China.1 passage
• Re-recognizing serological change patterns and antiviral therapy opportunity of patients with acute hepatitis B through highly sensitive detection technology.1 passage
• Real life experience of mycophenolate mofetil monotherapy in liver transplant patients.1 passage
• Real-world use of therapeutic drug monitoring of CT-P13 in patients with inflammatory bowel disease: A 12-month prospective observational cohort study.1 passage
• Reasons for chemotherapy discontinuation and end-of-life in patients with gastrointestinal cancer: A multicenter prospective AGEO study.1 passage
• Recent developments in the research on biomarkers of cholangiocarcinoma in primary sclerosing cholangitis.1 passage
• Recipient gender and body mass index are associated with early acute rejection in donation after cardiac death liver transplantation.1 passage
• Recommendations on diagnosis and treatment in hepatobiliary surgery under 2019-nCoV epidemic.1 passage
• Regulatory T cell therapy: An option to induce operational tolerance in liver transplantation.1 passage
• Relationship between IL28B gene rs8099917 polymorphism and SVR in Turkish patients with hepatitis C virus genotype 1.1 passage
• Relationship between NR1I2 polymorphisms and inflammatory bowel disease risk: A systematic review and meta-analysis.1 passage
• Renal function in patients receiving streptozocin for locally advanced or metastatic digestive neuroendocrine tumours: results of the Streptotox-FFCD 0906 study.1 passage
• Repeat surgery in HNF1alpha-inactivated adenomatosis.1 passage
• Rescue therapy with bismuth-containing quadruple therapy in patients infected with metronidazole-resistant Helicobacter pylori strains.1 passage
• Resident liver progenitor cells: Proofs of their contribution to human liver regeneration.1 passage
• Resistance-associated mutations to HCV protease inhibitors naturally pre-existed in HIV/HCV coinfected, treatment-naïve patients.1 passage
• Reversibility of liver fibrosis.1 passage
• Rhabdomyolysis and coeliac disease: A causal or casual association? A case report and review of literature.1 passage
• Risk factors for vascular liver diseases: Vascular liver diseases: position papers from the francophone network for vascular liver diseases, the French Association for the Study of the Liver (AFEF), and ERN-rare liver.1 passage
• Risk factors of de novo malignancies after liver transplantation: a French national study on 11004 adult patients.1 passage
• Risk factors of recurrence among 471 Chinese patients with Budd-Chiari syndrome.1 passage
• Risk of adverse events in advanced hepatocellular carcinoma with immune checkpoint therapy: A systematic review and meta-analysis.1 passage
• Risk of metachronous advanced lesions after resection of diminutive and small, non-advanced adenomas.1 passage
• Role of HCV-RNA decay and IP-10 levels after 48 hours of standard HCV therapy as predictors of rapid virological response.1 passage
• Role of circulating tumor DNA in the management of patients with colorectal cancer.1 passage
• Role of interleukin-23 in monocyte-derived dendritic cells of HBV-related acute-on-chronic liver failure and its correlation with the severity of liver damage.1 passage
• Role of vitamin D deficiency as a risk factor for infections in cirrhotic patients.1 passage
• Rooibos, a fake friend.1 passage
• Safety and efficacy of palliative systemic chemotherapy combined with colorectal self-expandable metallic stents in advanced colorectal cancer: A multicenter study.1 passage
• Salvage liver transplantation for hepatocellular carcinoma recurrence after primary liver resection.1 passage
• Screening for rare variants in the PNPLA3 gene in obese liver biopsy patients.1 passage
• Seroprevalence of Hepatitis E virus infection in children after liver transplantation: A single-center experience in France.1 passage
• Serum IgG4 and IgG for the diagnosis of autoimmune pancreatitis: A systematic review with meta-analysis.1 passage
• Serum S100 calcium binding protein A4 improves the diagnostic accuracy of transient elastography for assessing liver fibrosis in hepatitis B.1 passage
• Serum anti-TOPO48 autoantibody as a biomarker for early diagnosis and prognosis in patients with esophageal squamous cell carcinoma.1 passage
• Serum immune biomarkers in irritable bowel syndrome.1 passage
• Serum miR-21, miR-26a and miR-101 as potential biomarkers of hepatocellular carcinoma.1 passage
• Serum miR-224 as a biomarker for detection of hepatocellular carcinoma at early stage.1 passage
• Severe immune-related hepatitis induced by immune checkpoint inhibitors: Clinical features and management proposal.1 passage
• Severe takotsubo cardiomyopathy following orthotopic liver transplantation: A case series.1 passage
• ShRNA-mediated silencing of the Ndc80 gene suppress cell proliferation and affected hepatitis B virus-related hepatocellular carcinoma.1 passage
• Shwachman-Diamond syndrome with autoimmune-like liver disease and enteropathy mimicking celiac disease.1 passage
• Significance of microRNA 21 in gastric cancer.1 passage
• Significant histological changes and satisfying antiviral efficacy in chronic hepatitis B virus infection patients with normal alanine aminotransferase. Antiviral therapy decision in chronic HBV patients with normal ALT.1 passage
• Simple blood fibrosis tests reduce unnecessary referrals for specialized evaluations of liver fibrosis in NAFLD and ALD patients.1 passage
• Simultaneous pancreas and kidney transplantation for liver transplant recipients with diabetes and uremia.1 passage
• Sinusoidal obstruction syndrome.2 passages
• Skeletal muscle loss during chemotherapy and its association with survival and systemic treatment toxicity in metastatic colorectal cancer: An AGEO prospective multicenter study.1 passage
• Skeletal status assessed by quantitative ultrasound and dual-energy X-ray absorptiometry in children with inflammatory bowel disease: A 2-year prospective study.1 passage
• Small bowel capsule endoscopy: May we delegate it to nurses?1 passage
• Small colorectal cancers resembling submucosal tumor with massive submucosal invasion and lymph node metastasis: A report of two cases and review of the literature.1 passage
• Small for Size and Flow (SFSF) syndrome: An alternative description for posthepatectomy liver failure.1 passage
• Snapshot summary of diagnosis and management of hepatocellular adenoma subtypes.1 passage
• Sodium taurocholate co-transporting polypeptide deficiency.1 passage
• Sofosbuvir in combination with daclatasvir in liver transplant recipients with HCV infection: A systematic review and meta-analysis.1 passage
• Spontaneous tumour lysis syndrome in hepatocellular carcinoma presenting with hypocalcemic tetany: An unusual case and systematic literature review.1 passage
• Statin use and virus-related cirrhosis: A systemic review and meta-analysis.1 passage
• Statins use and the prognosis of colorectal cancer: a meta-analysis.1 passage
• Steatotic hepatocellular adenomas with different phenotypic subtypes: a case report.1 passage
• Stress-induced cellular responses and cell death mechanisms during inflammatory cholangiopathies.1 passage
• Subclinical hypothyroidism as an independent risk factor for colorectal neoplasm.1 passage
• Suggestions for the care of patients with liver disease during the Coronavirus 2019 pandemic.1 passage
• Sulfasalazine, a therapeutic agent for ulcerative colitis, inhibits the growth of CD44v9(+) cancer stem cells in ulcerative colitis-related cancer.1 passage
• Surgical management of oligometastatic disease in gastric cancer.1 passage
• Surgical outcomes between patients with and without a cirrhotic liver undergoing laparoscopic liver resection: A meta-analysis.1 passage
• Surgical rather than endoscopic resection of early-stage colorectal cancers promotes excessive imaging surveillance.1 passage
• Surgical resection of primary tumor is associated with prolonged survival in low-grade pancreatic neuroendocrine tumors.1 passage
• Survival according to recurrence patterns after resection for transplantable hepatocellular carcinoma in HBV endemic area: Appraisal of liver transplantation strategy.1 passage
• Survival analysis of sirolimus-based immunosuppression in liver transplantation in patients with hepatocellular carcinoma.1 passage
• Survival in relation to hospital type after resection or sorafenib treatment for hepatocellular carcinoma in The Netherlands.1 passage
• Sustained virologic response and other potential genotype-specific roles of statins among patients with hepatitis C-related chronic liver diseases.1 passage
• Synergy between NAFLD and AFLD and potential biomarkers.1 passage
• Systematic review of progressive familial intrahepatic cholestasis.1 passage
• Systematic review on the prevalence of nonalcoholic fatty liver disease in South Korea.1 passage
• Systematic upper endoscopy concomitant with colonoscopy performed within the colorectal cancer screening program: Impact on the patients' management.1 passage
• TERT promoter mutations in primary liver tumors.1 passage
• TIPS for management of portal-hypertension-related complications in patients with cirrhosis.1 passage
• TNF-α-308/-238 polymorphisms are associated with gastric cancer: A case-control family study in China.1 passage
• Takotsubo cardiomyopathy triggered by delirium tremens in a cirrhotic patient with acute-on-chronic liver failure: A case report.1 passage
• Targeting Mcl-1 inhibits survival and self-renewal of hepatocellular cancer stem-like cells.1 passage
• Telemedicine in the COVID-19 era for Liver Transplant Recipients: an Italian lockdown area experience.1 passage
• Temporal trends of pancreatic ductal adenocarcinoma in young adults in the United States: A Population-Based Study.1 passage
• Th17/Treg imbalance is an indicator of liver cirrhosis process and a risk factor for HCC occurrence in HBV patients.1 passage
• Thalidomide is a therapeutic agent that is effective in inducing and maintaining endoscopic remission in adult CD patients.1 passage
• The Ability of the Framingham Steatosis Index (FSI) to Predict Non-alcoholic Fatty Liver Disease (NAFLD): A Cohort Study.1 passage
• The MBOAT7 rs641738 variant is associated with an improved outcome in primary sclerosing cholangitis.1 passage
• The Time to Advocate for Influenza Vaccines in Patients with Cirrhosis is Now.1 passage
• The addition of S-1 to gemcitabine-based chemotherapy improves survival with increased toxicity for patients with advanced pancreatic cancer: combined meta-analysis of efficacy and safety profile.1 passage
• The aged liver: Beyond cellular senescence.1 passage
• The association between non-alcoholic fatty liver disease and atrial fibrillation: A meta-analysis.1 passage
• The association between vitamin D receptor polymorphisms and serum 25-hydroxyvitamin D levels with ulcerative colitis in Chinese Han population.1 passage
• The association of the vitamin D status with the persistence of anti-HBs antibody at 20years after primary vaccination with recombinant hepatitis B vaccine in infancy.1 passage
• The association of variations in TLR genes and spontaneous immune control of hepatitis B virus.1 passage
• The clinical effect of early enteral nutrition in liver-transplanted patients: a systematic review and meta-analysis.1 passage
• The clinical value of kinesin superfamily protein 2A in hepatocellular carcinoma.1 passage
• The clinical, prognostic and therapeutic significance of liver cancer stem cells and their markers.1 passage
• The development of hepatocarcinoma after long-term antivirus treatment of Chinese patients with chronic hepatitis B virus infection: Incidence, long-term outcomes and predictive factors.1 passage
• The development of statin-based therapy for patients with hepatitis C virus (HCV) infection using human induced pluripotent stem (iPS) cell technology.1 passage
• The diagnosis of antimitochondrial antibody-negative primary biliary cholangitis.1 passage
• The diagnostic efficacy of CYFRA21-1 on intrahepatic cholangiocarcinoma: A meta-analysis.1 passage
• The dynamic of platelet count as a novel and valuable predictor for 90-day survival of hepatitis B virus-related acute-on-chronic liver failure patients.1 passage
• The early prognostic value of inflammatory markers in patients with acute pancreatitis.1 passage
• The effect of maternal use of telbivudine on neonatal CD41 passage
• The effect of omeprazole treatment on the gut microflora and neutrophil function.1 passage
• The effect of peginterferon alpha-2a vs. interferon alpha-2a on intrahepatic covalently closed circular DNA in HBeAg-positive chronic hepatitis B patients.1 passage
• The effect of reminiscence therapy-involved care on anxiety, depression, life quality and survival in colorectal cancer patients.1 passage
• The effectiveness of Lactobacillus reuteri DSM 17938 as an adjunct to macrogol in the treatment of functional constipation in children. A randomized, double-blind, placebo-controlled, multicentre trial.1 passage
• The efficacy and safety of 5-fluorouracil based adjuvant therapy in resected biliary tract cancer: A systematic review and meta-analysis.1 passage
• The efficacy of adjuvant N acetyl cysteine for the eradication of H pylori infections: A systematic review and meta-analysis of randomized clinical trials.1 passage
• The epigenetics of PBC: The link between genetic susceptibility and environment.1 passage
• The gamma-glutamyl transpeptidase to platelet ratio predicts liver inflammation in chronic hepatitis B with normal or mildly elevated alanine transaminase.1 passage
• The gut microbiome as a target for adjuvant therapy in insomnia disorder.1 passage
• The interplay between the intestinal microbiota and the immune system.1 passage
• The liver injury and gastrointestinal symptoms in patients with Coronavirus Disease 19: A systematic review and meta-analysis.1 passage
• The longitudinal changes of anxiety and depression, their related risk factors and prognostic value in colorectal cancer survivors: a 36-month follow-up study.1 passage
• The multiple origin of cancer stem cells in hepatocellular carcinoma.1 passage
• The noninvasive diagnosis of esophageal varices and its application in clinical practice.1 passage
• The pathological role of microRNAs and inflammation in colon carcinogenesis.1 passage
• The pathophysiology of intrahepatic cholestasis of pregnancy.1 passage
• The predictors of mortality and secular changes in management strategies in emphysematous gastritis.1 passage
• The prognostic role of Helicobacter pylori in gastric cancer patients: A meta-analysis.1 passage
• The prognostic role of Leucine-rich repeat-containing G-protein-coupled receptor 5 in gastric cancer: A systematic review with meta-analysis.1 passage
• The quality of hereditary haemochromatosis guidelines: a comparative analysis.1 passage
• The reasonable drainage option after laparoscopic common bile duct exploration for the treatment of choledocholithiasis.1 passage
• The relationship between cardiac muscularis propria and clinical outcomes of peroral endoscopic myotomy in achalasia.1 passage
• The relationship between inflammatory bowel disease and rosacea over the lifespan: A meta-analysis.1 passage
• The role of ROS-induced autophagy in hepatocellular carcinoma.1 passage
• The role of acetic acid in the management of Barrett's oesophagus.1 passage
• The role of linear endosonography for the diagnosis of acute pancreatitis when other methods failed.1 passage
• The role of serum intestinal fatty acid binding protein levels and D-lactate levels in the diagnosis of acute intestinal ischemia.1 passage
• The safety and efficacy of anti-PD-1/anti-PD-L1 antibody therapy in the treatment of previously treated, advanced gastric or gastro-oesophageal junction cancer: A meta-analysis of prospective clinical trials.1 passage
• The type of KRAS mutation drives PI3Kα/γ signalling dependency: Implication for the choice of targeted therapy in pancreatic adenocarcinoma patients.1 passage
• The use of biofeedback for children with fecal incontinence secondary to retentive constipation: Experience of a French Pediatric Center.1 passage
• The utility of NAFLD fibrosis score for prediction of mortality among patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis of cohort study.1 passage
• The utility of food antigen test in the diagnosis of Crohn's disease and remission maintenance after exclusive enteral nutrition.1 passage
• The value of severe vitamin D deficiency in predicting the mortality risk of patients with liver cirrhosis: A meta-analysis.1 passage
• The visceral adiposity index is a predictor of incident nonalcoholic fatty liver disease: A population-based longitudinal study.1 passage
• Therapeutic drug monitoring is predictive of loss of response after de-escalation of infliximab therapy in patients with inflammatory bowel disease in clinical remission.1 passage
• Therapeutic efficacy and safety of umbilical cord mesenchymal stem cell transplantation for liver cirrhosis in Chinese population: A meta-analysis.1 passage
• Therapeutic management of alcoholic hepatitis.1 passage
• Thermal ablation of medium-sized hepatocellular carcinomas using intraoperative ultrasound fusion imaging: A propensity score-matched analysis.1 passage
• Three fluoropyrimidine-based regimens in routine clinical practice after nab-paclitaxel plus gemcitabine for metastatic pancreatic cancer: An AGEO multicenter study.1 passage
• Thymidylate synthase gene polymorphisms as important contributors affecting hepatocellular carcinoma prognosis.1 passage
• Toxic hepatitis due to a food supplement: "Natural" is no synonym for "harmless".1 passage
• Trans-anethole attenuates diet-induced nonalcoholic steatohepatitis through suppressing TGF-β-mediated fibrosis.1 passage
• Transglutaminase 3 expression in hepatocellular carcinoma patients: Correlation with tumor features and survival profile.1 passage
• Transient elastography for assessment of fibrosis and steatosis of liver grafts from brain-death donors.1 passage
• Transient elastography through controlled attenuated parameter assisting the stratification of cardiovascular disease risk in NAFLD patients.1 passage
• Treatment of anal fissures: Results from a national survey on French practice.1 passage
• Treatment of hepatitis C virus infection.1 passage
• Treatment of primary biliary cholangitis with ursodeoxycholic acid, prednisolone and immunosuppressants in patients not responding to ursodeoxycholic acid alone and the prognostic indicators.1 passage
• Treatment response, survival and safety profile of transarterial chemoembolization using different sizes of drug-eluting beads in hepatocellular carcinoma patients with portal vein tumor thrombus.1 passage
• Treatment with mTOR inhibitors after liver transplantation enables a sustained increase in regulatory T-cells while preserving their suppressive capacity.1 passage
• Trimetazidine alone or in combination with gemcitabine and/or abraxane decreased cell viability, migration and ATP levels and induced apoptosis of human pancreatic cells.1 passage
• Tumor educated platelets, a promising source for early detection of hepatocellular carcinoma: Liquid biopsy an alternative approach to tissue biopsy.1 passage
• Tumor-associated autoantibodies against Fascin as a novel diagnostic biomarker for esophageal squamous cell carcinoma.1 passage
• Two new mutations of the CLMP gene identified in a newborn presenting congenital short-bowel syndrome.1 passage
• Two-stage liver transplantation using auxiliary laparoscopically harvested grafts in adults: Emphasizing the concept of "hypersmall graft nursing".1 passage
• Tyrosine kinase-2 gene polymorphisms are associated with ulcerative colitis and Crohn's disease in Turkish Population.1 passage
• USP9X mRNA expression predicts clinical outcome for esophageal squamous cell carcinoma treated with cisplatin-based therapy.1 passage
• Ubiquitin-conjugating enzyme E2T(UBE2T) promotes colorectal cancer progression by facilitating ubiquitination and degradation of p53.1 passage
• Unclassified hepatocellular adenoma expressing ASS1 associated with inflammatory hepatocellular adenomas.1 passage
• Uncommon presentation of COVID-19: Gastrointestinal bleeding.1 passage
• Up-regulation of miR-498 inhibits cell proliferation, invasion and migration of hepatocellular carcinoma by targeting FOXO3.1 passage
• Upper gastrointestinal bleeding in COVID-19 inpatients: Incidence and management in a multicenter experience from Northern Italy.1 passage
• Upper gastrointestinal video capsule endoscopy: The state of the art.1 passage
• Vaccination in adult liver transplantation candidates and recipients.1 passage
• Validating the BAVENO VI criteria to identify low risk biliary atresia patients without endoscopy for esophageal varix.1 passage
• Validation of the French version of the esophageal hypervigilance and anxiety scale.1 passage
• Vena Cava and Pancreatic head En Bloc Resection for an Invasive Inferior Vena Cava Leiomyosarcoma in a Liver Transplant Patient.1 passage
• Vitamin D deficiency negatively affects both the intestinal epithelial integrity and bone metabolism in children with Celiac disease.1 passage
• Vitamin E in paediatric non-alcoholic fatty liver disease: a meta-analysis.1 passage
• What is the role of small bowel capsule endoscopy in established coeliac disease?1 passage
• Why and when to measure ammonemia in cirrhosis?1 passage
• Wilson disease: Health-related quality of life and risk for depression.1 passage
• Wilson's disease: A 2017 update.1 passage
• World Gastroenterology Organisation classification and a new type-based prognostic model for hepatitis B virus-related acute-on-chronic liver failure.1 passage
• ZFX promotes tumorigenesis and confers chemotherapy resistance in esophageal squamous cell carcinoma.1 passage
• Zinc monotherapy for young patients with oligosymptomatic Wilson disease: A single center, retrospective study.1 passage
• hsa-miR-93 regulates MUCIN family gene expression via WNT/β-catenin pathway in intrahepatic stone disease.1 passage
• mTOR inhibitors in pediatric liver transplant recipients.1 passage
• miR-744 is a potential prognostic marker in patients with hepatocellular carcinoma.1 passage